JBM Healthcare gets bitter pill from investors on anemic performance
Shares of the over-the-counter traditional Chinese medicine company tumbled after it reported sequential revenue and profit declines in the second half of its fiscal year Key Takeaways: JBM Healthcare’s profit…
Recent Articles
RELATED ARTICLES
-
Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare
2667.HK - Chinese medicine firm seeks elusive elixir of IPO success
- Good Doctor Cloud Healthcare’s ailing margins belie uninspired new listing
- Yidu Tech swings to profit as AI healthcare edges toward viability
- Cango eyes high-performance computing scale-up after turning a tight corner
- Slowing takeout dining wars leave Luckin with bitter aftertaste
-
BRIEF: Distinct Healthcare launches $41 million Hong Kong IPO
2677.HK
